We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
New measures strengthen the safe use of the acne drug isotretinoin for patients across the UK, following a patient-focused expert review
The AI-Airlock will assist in the development and deployment of software and AI medical devices, safely providing patients with earlier access to cutting edge innovations that improve care.
£21 million is being allocated to 64 NHS trusts across England to roll out AI tools to speed up the diagnosis and treatment of lung cancer.
First published during the 2022 to 2024 Sunak Conservative government
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
The Medicines and Healthcare products Regulatory Agency (MHRA), US Food and Drug Administration (FDA) and Health Canada have collaborated to identify five guiding principles for the development of predetermined change control plans (PCCPs).…
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
Patients with recurring lymphoma, or who have not responded to prior treatments, could access a new bispecific antibody therapy to help treat their condition.
No evidence of supply or harm to patients
The scheme will see the lowest-risk clinical trials processed by the MHRA in less than 14 days.
Patients to receive the latest valproate safety information with every pack, following changes to the Human Medicines Regulations, 2012
Automation is the future for manufacturing stem cells, says the Head of the Medicines and Healthcare products Regulatory Agency’s UK Stem Cell Bank (UKSCB) on its 20th Anniversary.
Parents and carers should talk to their healthcare professional about how to feed colostrum (first milk) safely to their baby.
Almost three years on from the approval in the UK of the first COVID-19 vaccine, the Medicines and Healthcare products Regulatory Agency (MHRA) pays tribute to the scientists who developed the technology behind the mRNA COVID vaccines, Dr Katalin Kariko and Dr Drew Weissman, who today…
For the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression
Awareness and action regarding increase of suspected adverse event reports following use of intravenous co-amoxiclav (amoxicillin and clavulanic acid) products.
Businesses across the UK will have the opportunity to showcase that their new AI and digital innovations comply with regulatory standards, so they can quickly bring them to market.
The Innovative Devices Access Pathway (IDAP) pilot was launched today by the Department of Health and Social Care (DHSC), Health Technology Wales (HTW), the Medicines and Healthcare products Regulatory Agency (MHRA), the National Health Service England (NHSE), the National Institute for…
The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and effectiveness.
More information following our investigation into an increase of adverse event reports following the cascade use of intravenous co-amoxiclav (amoxicillin and clavulanic acid) products.
Government invests £200 million of new funding to boost NHS resilience and ensure patients receive the care they need this winter.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).